Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

H. Pfeifer,Gianni Cazzaniga,Vincent van der Velden,Jean-Michel Cayuela,B. Schäfer,O. Spinelli,Susanna Akiki,S. Avigad,I. Bendit,K. Borg,Helene Cavé, L. Elia,S. C. Reshmi,Gareth Gerrard,Sandrine Hayette, Spencer Hermanson, A. Juh,Tomáš Jurcek,Carmen Chillón,Christa Homburg,G. Martinelli, V. Kairisto,T. Lange,T. Lion, M. C. Mueller,F. Pane, L. Rai, C. Damm-Welk, T Sacha,Susanne Schnittger, T Touloumenidou, H. Valerhaugen,Peter Vandenberghe, J. Zuna,Hubert Serve,E. Herrmann,S. Markovic,J. J.M. van Dongen, O.G. Ottmann

LEUKEMIA（2020）

引用 2|浏览55

暂无评分

摘要

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

查看译文

关键词

Acute lymphocytic leukaemia,Genetic testing,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要